Sage Rhino Capital LLC Novo Nordisk A S Transaction History
Sage Rhino Capital LLC
- $407 Million
- Q2 2024
A detailed history of Sage Rhino Capital LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Sage Rhino Capital LLC holds 12,330 shares of NVO stock, worth $1.44 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
12,330
Previous 12,320
0.08%
Holding current value
$1.44 Million
Previous $1.58 Million
11.26%
% of portfolio
0.43%
Previous 0.38%
Shares
21 transactions
Others Institutions Holding NVO
# of Institutions
1,990Shares Held
318MCall Options Held
5.23MPut Options Held
4.97M-
Jennison Associates LLC21.2MShares$2.47 Billion1.95% of portfolio
-
Morgan Stanley New York, NY14.6MShares$1.7 Billion0.16% of portfolio
-
Bank Of America Corp Charlotte, NC14.2MShares$1.65 Billion0.18% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$1.56 Billion0.83% of portfolio
-
Fayez Sarofim & CO Houston, TX12.6MShares$1.46 Billion4.91% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $263B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...